Featured companies:
Entheon Biomedical Corp. (CSE: ENBI, OTCQB: ENTBF)
Researching and developing DMT, one of the most powerful of its kind in existence, to address substance use disorders related to nicotine, alcohol, and more.
Psyched Wellness Ltd. (CSE: PSYC, OTCQB: PSYCF)
BTV reports on their pre-clinical studies underway with a proprietary extract from the Amanita Muscaria mushroom. Psyched Wellness was created with the purpose of benefitting the health of people, plants and the planet.
Small Pharma Inc. (TSX.V: DMT)
BTV learns about DMT, the subject of a Small Pharma clinical trial dealing with depression – the world’s first. Small Pharma initiated a clinical program into DMT-assisted therapy in February 2021. Elemer Piros, Analyst at Roth Capital Partners, weighs in.
Numinus Wellness Inc. (TSX.V: NUMI)
BTV checks in with a company at the forefront of a new and innovative mental health treatment. The company is looking to transform the mental health landscape.
Mydecine Innovations Group (NEO: MYCO, OTC: MYCOF)
BTV discovers how this company is developing treatments to better address the effects of addiction and post-traumatic stress disorder.
On air for over 20 years, BTV – Business Television, a half-hour investment TV show, features analysts and emerging publicly traded companies at their location. With Hosts, Taylor Thoen and Jessica Katrichak, BTV provides viewers with investment opportunities.
#MYCOF, #NUMI, #DMT, #PSYCF, #ENTBF
